Carl Zeiss Meditec | Sustainability Performance
Develops and markets medical devices and solutions for ophthalmology and microsurgery applications.
2002
Germany
5,001 - 10,000 employees
Medical Device
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8263
Overallⓘ#415
in Germanyⓘ#133
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Carl Zeiss Meditec AG, German major ophthalmology/microsurgery medical devices (Carl Zeiss Foundation 59% controlled, listed), has faced multiple US class actions over alleged inadequate disclosure of US/European ophthalmology customer demand normalization following the contested 2024 sustained share price volatility amid postCOVID ophthalmology customer demand normalization affecting German institutional shareholders amid global ophthalmology sector pressure.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.